Drug Approval Process in Europe - An Outlook

Share this:
     
Published: 22 Dec 2008

This research deals with the drug approval process in Europe by focussing on the various marketing authorisation procedures, price controls and parallel trading. A snapshot of the biosimilars approval process is also provided along with the key strategic recommendations.

  1.  
  2.  
  3.  
  4.  
  5.  
  6.  
  7.  
  8.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..